It takes two flints to make a fire
Projects
With a track record of successfully delivering complex projects, our expertise spans the full spectrum of biotech and pharma manufacturing. From concept to execution, we provide innovative solutions tailored to the evolving needs of the biotechnology, pharmaceutical, and advanced therapy industries.
Our experience includes, but is not limited to:
4.7
★★★★★ 5/5
Rating Customer
Lorem ipsum dolor sit amet, consectetur adipiscing elit.
A+
★★★★★ 5/5
Software Class
Lorem ipsum dolor sit amet, consectetur adipiscing elit.
Generic Pharma
Small Molecules
Blood Plasma
large Molecules – Biologics
Vaccines & mRNA Therapeutics
Viral Victor – Cell & Gene Therapy
GMP Engineering
€500M
Project Value
Feasibility and Concept
30,000 m² Facility
$1.5B
OVER 10 Years Project Value
250 Acres Vaccine
Manufacturing, Inspection
& Fill-Finish Facility
€500M
Project Value
100,000 m² Bulk
Vaccine Facility
€200M
Project Value
60,000 m² Bulk Vaccine
Facility
€350M
Project Value
46,000 m² Bulk
Vaccine Facility
$100M
Project Value
Recombinant
Manufacturing Facility
$450M
Project Value
High Potent Modality
Agnostic Large Scale
Pilot Plant
$100M
Project Value
Recombinant
Manufacturing Facility
GMP Engineering
$14M
Project Value
20,500 sq. ft. New GMP
Facility for solid oral
dosage manufacturing
$4M
Project Value
4000 sq. ft. New GMP
Cell & Gene Therapy
Manufacturing Space
$140M
Project Value
For upgrading process
and automation systems
(upstream, downstream
and supporting utilities/
buffers/CIP)
$100M
Project Value
Providing entire end
to end C&Q service
scope for Greenfield
OSD site
$50M
Project Value
PM and C&Q for mRNA
vaccine manufacturing
process and a singleuse bioprocess facility
expansion
$670M
Project Value
PM/Owner Rep Plasma
Facility expansion
(Process, Automation,
Utilities, Architecture)
$100M
Project Value
Capital project
management and
project controls for two
train, and Tank Farm
expansion projects
$100M
Project Value
Recombinant
Manufacturing Facility
GMP Engineering
€100M
Project Value
25,000 square meter,
Development of the
vaccine facility, including
the establishment of
QC (Quality Control)
areas
€60M
Project Value
16,000 square meter,
New facility featuring
two generic OSD (Oral
Solid Dosage) lines,
one liquid production
line, and two injectable
lines (LVP + SVP),
along with all required
utilities
$250M
Project Value
100,000 square meter,
Pharmaceutical
hub comprising
four manufacturing
buildings (OSD, OSD
Cephalosporins, OSD
Beta-Lactams, and
Injectables – 1x LVP +
2x SVPs), along with
a dedicated QC and
R&D building and all
necessary utilities
€200M
Project Value
60,000 m² Bulk Vaccine
Facility
€350M
Project Value
46,000 m² Bulk
Vaccine Facility
$100M
Project Value
Recombinant
Manufacturing Facility
$450M
Project Value
High Potent Modality
Agnostic Large Scale
Pilot Plant
€350M
Project Value
46,000 m² Bulk
Vaccine Facility
$100M
Project Value
Recombinant
Manufacturing Facility
Clients
